抗氧化应激转录因子Nrf2在血管钙化发生中的作用及机制研究
[Abstract]:The oxidative stress of the first part of the anti-oxidative stress transcription factor Nrf2 in the vascular calcification model of the rat induced by VDNN is a common pathological factor of the blood vessel calcification combined with various diseases, but the research of the anti-oxidative stress mechanism to the vascular calcification is still to be studied. This study is to explore the changes of endogenous anti-oxidative stress transcription factor Nrf2 and its regulated downstream anti-oxidative stress molecule in the vascular calcification model (VDN) induced by vitamin D3 (Vitamine D3) and nicotine (Nicotine), The role of this in the occurrence of vascular calcification was demonstrated by the in vivo study. Methods Twenty two-month-old Wistar male rats were randomly divided into the control group and the VDN calcified group. The rats were given nicotine (25mg/ kg) and vitamin D3 (30 000 units/ kg) intramuscularly at 9 o 'clock in the calcified group, and the nicotine was given at 6: 00 at night for one time. The control group was given saline injection. After two months, rat blood vessel tissue: silver nitrate staining was used to determine the degree of blood vessel calcification; the content of calcium and ALP activity of the tissue were determined by the kit; Western blot was used to detect the expression of bone marker protein Runx2, OPN, and Catenin, and the expression of Nrf2 and its downstream anti-oxidation enzyme NQO1 was also detected. Results Compared with the control group, there was a significant increase in the levels of calcium and ALP in the vascular middle layer of the VDN-calcified group (P0.05), and the expression of the bone marker protein Runx2, OPN, and Catenin increased significantly (P0.05). The expression of Nrf2 and its induced antioxidant NQO1 in the vascular tissue of the VDN-calcified group was also increased. Conclusion Nrf2 and its downstream anti-oxidation enzyme NQO1 were activated in the vascular calcification induced by VDNN, and were involved in the occurrence of vascular calcification. The effect of the second part of the anti-oxidative stress transcription factor Nrf2 on the calcification of high-phosphorus-induced vascular smooth muscle cells and its molecular mechanism are the main mechanism of vascular smooth muscle cells (VSMCs) to participate in and control the vascular calcification. As the most important endogenous anti-oxidative stress transcription factor, Nrf2 plays a key role in the prevention of oxidative stress, and has significant anti-oxidative stress and anti-apoptotic effects. The purpose of this study was to investigate the role of Nrf2 on the calcification of vascular smooth muscle cells induced by high phosphorus and its molecular mechanism. Methods The primary vascular smooth muscle cells of Wistar rats were divided into control group, calcification group, Nrf2 silencing group and Nrf2 activation group. The control group was cultured with normal medium, and 10 mM triphosphoglycerate (PGP) was given to the cell culture medium of the calcified group, and the specific Nrf2 activator DMF and tBHQ were selected for the Nrf2 activated group cells, and the Nrf2 expression was silenced by the RNA interference technique in the Nrf2 silencing group cells. The expression of Nrf2 and its downstream NQO1 and HO1 in each group was detected by Western blot and RT-PCR, and the expression of BMP2, Runx2, OPN and Catenin in each group was detected by Western blot and RT-PCR. The cell apoptosis and the expression of clear caspase3 were detected by flow cytometry and Western blot. The activity of ROS and the content of MDA were detected by flow cytometry and kit. Results Compared with the control group, the content of the intracellular calcium and the activity of ALP increased significantly after 10 days after the cell culture of the calcified group, and the expression of the bone marker protein BMP2, Runx2, OPN and Catenin increased significantly, and the activity of ROS and the content of MDA increased significantly. The expression of clear caspase3 and the cell apoptosis rate were also increased. Compared with the control group, the mRNA level of Nrf2 in the Nrf2 group was reduced by about 70%, and the expression of NQO1 and HO1 downstream of Nrf2 was also significantly decreased, while the expression of the bone marker protein BMP2, Runx2, OPN, and Catenin increased significantly, and the content of calcium in the cells increased significantly. Compared with the calcified group, the Nrf2 downstream anti-oxidation enzyme NQO1 was significantly activated after the intervention of the Nrf2 activator DMF and tBHQ, while the expression of the bone marker protein BMP2, Runx2, OPN, and Catenin decreased significantly, and the ROS activity and MDA content of the cells decreased significantly, and the clear caspase3 expression and the cell apoptosis rate were also significantly reduced. Conclusion Nrf2 can reduce the oxidative stress and apoptosis of vascular smooth muscle cells by inhibiting the transformation of bone-like phenotype of high-phosphorus-induced vascular smooth muscle cells, and further inhibit the occurrence of high-phosphorus-induced vascular smooth muscle cell calcification.
【学位授予单位】:华中科技大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R54
【相似文献】
相关期刊论文 前10条
1 ;血管钙化转化医学研究进展研讨会第一轮通知[J];中国病理生理杂志;2011年04期
2 ;血管钙化转化医学研究进展研讨会第二轮通知[J];生理科学进展;2011年03期
3 张晓敏;汤日宁;刘必成;;血管钙化相关抑制因子的研究进展[J];中华高血压杂志;2013年03期
4 邵文;李书国;;血管平滑肌细胞与血管钙化机制的研究进展[J];医学综述;2013年16期
5 江太发;;血管钙化也危险[J];山西老年;2011年02期
6 张宝红,杜军保;血管钙化的调节机制[J];心血管病学进展;2003年03期
7 杨英;血管钙化[J];内蒙古医学院学报;2004年02期
8 杨晓玲,曹军;血管钙化的分子机制[J];宁夏医学院学报;2005年04期
9 阙利亚;侯兰;刘梅莹;;终末期肾功能衰竭患者血管钙化发生事件分析[J];中国热带医学;2007年03期
10 张训;;血液透析患者血管钙化的防治[J];中国血液净化;2007年05期
相关会议论文 前10条
1 王莉;丁涵露;;血管钙化与钙磷[A];中华医学会肾脏病学分会2010学术年会专题讲座汇编[C];2010年
2 齐永芬;唐朝枢;;血管钙化发病机制研究新进展[A];中华医学会第十三次全国心血管病学术会议专题报告专辑[C];2011年
3 张训;;慢性肾脏病病人的血管钙化[A];中华医学会肾脏病学分会2006年学术年会专题讲座[C];2006年
4 游怀舟;丁峰;杨海春;顾勇;林善锬;;尿毒症患者体内高级蛋白氧化产物对血管钙化的作用及其机制探讨[A];中华医学会肾脏病学分会2006年学术年会论文集[C];2006年
5 孙文学;刘毅;阮吉;徐玉兰;;雌激素对大鼠血管钙化消退影响的研究[A];2012年浙江省肾脏病学术年会论文集[C];2012年
6 刘毅;;慢性肾功能衰竭血管钙化防治研究进展[A];中华医学会第11届全国内科学术会议论文汇编[C];2007年
7 王中群;;尿毒症大鼠血管钙化的实验研究[A];中国微循环学会2011年全国学术会议论文汇编[C];2011年
8 李开龙;王燕;李柱宏;陈菁;林利容;李开斌;何娅妮;;他汀类药物对维持性血透患者血管钙化的影响[A];西南地区第12届肾脏病学术会议暨贵州省医学会肾脏病学分会2012年学术会议论文集[C];2012年
9 李开龙;何娅妮;王惠明;苏楠;詹俊;赵玲;陈林;;维持性血透患者外周血成纤维细胞生长因子23水平与血管钙化关系的研究[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年
10 江瑛;王梅;;高磷与慢性肾衰竭大鼠血管钙化的关系研究[A];中华医学会肾脏病学分会2006年学术年会论文集[C];2006年
相关博士学位论文 前9条
1 鲁燕;脂联素在内质网应激致血管钙化过程中的作用及其机制[D];山西医科大学;2015年
2 李恩刚;银杏叶提取物对高磷诱导的慢性肾脏病大鼠血管钙化作用的研究[D];山东大学;2016年
3 王金丽;抗氧化应激转录因子Nrf2在血管钙化发生中的作用及机制研究[D];华中科技大学;2016年
4 游怀舟;高级蛋白氧化产物在血管钙化中的作用及其机制探讨[D];复旦大学;2007年
5 张萍;高磷和慢性炎症对血管平滑肌细胞钙化的影响及相关调节机制的研究[D];浙江大学;2004年
6 王宁宁;尿毒症患者血管钙化的组织学研究及相关分子机制的探讨[D];南京医科大学;2006年
7 刘立新;体外血管钙化与细胞增殖的关系及其氟伐他汀对钙化影响的实验研究[D];中国人民解放军军医进修学院;2003年
8 赵安菊;血管钙化相关因子在糖尿病鼠肾小动脉中的表达及其与血管内膜/中膜增厚关系的初步探讨[D];四川大学;2007年
9 张静;KLF5介导高磷诱导的Runx2表达和血管平滑肌细胞成骨样分化[D];河北医科大学;2014年
相关硕士学位论文 前10条
1 刘国栋;白藜芦醇抑制维生素D3和尼古丁诱导大鼠血管钙化的作用及机制研究[D];中国人民解放军医学院;2015年
2 靳晶晶;镁通过调节钙化相关因子的表达抑制血管钙化[D];河北医科大学;2015年
3 杨锐;硫化氢抑制内质网应激改善大鼠主动脉血管钙化[D];河北医科大学;2015年
4 孟芸;大鼠牙周炎与血管钙化关系的研究[D];青岛大学;2015年
5 徐燕;血液透析患者血清FGF-23水平与血管钙化的相关性研究[D];苏州大学;2015年
6 陈瑶;CD137分子对小鼠血管钙化的影响[D];江苏大学;2016年
7 殷蕾;CKD5期透析伴心血管钙化患者中医证素的临床调查[D];南京中医药大学;2016年
8 常美香;营养不良—炎症综合征对维持性血液透析患者心血管钙化的影响[D];昆明医科大学;2016年
9 冯雪;维持性血液透析患者sclerostin与血管钙化之间的关系[D];河北医科大学;2016年
10 郭利萍;酸性及碱性环境对慢性肾衰竭大鼠血管钙化的影响[D];河北医科大学;2016年
,本文编号:2346150
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2346150.html